Therapy First
6.4K posts
@TherapyFirstOrg
Raising the quality of care for youth gender dysphoria. Training and supporting clinicians to deliver developmentally sound mental health care.
The new reviews add to a list of now over 20 systematic reviews, all of which come to the conclusion: evidence is insufficient to support the practice of pediatric medical gender transition. Puberty blockers are already permanently banned in the UK in both public (NHS) and private settings. Cross-sex hormones for minors were still technically allowed but with significant restrictions implemented post-Cass as we described in our spotlight. The March NHS England announcement indicates a permanent ban on puberty blocker in the NHS settings is being considered. Whether or not it will be extended to private settings is as yet unknown. The consultation period for the proposed NHS ban ends on June 7, 2026. /3 segm.org/England-UK-Pub…
📰A new paper highlights the known risks of puberty blockers for adolescent females—risks that have long been recognized in the gynecological literature. These findings have important implications for both clinical practice and the design of the PATHWAYS trial. Link below. /1
